Home/Drive Therapeutics/Doug Gooding

DG

Doug Gooding

CEO

Drive Therapeutics

Therapeutic Areas

Ophthalmology Retinal Diseases

Drive Therapeutics Pipeline

Drug	Indication	Phase
Undisclosed Aptamer Program	Wet Age-Related Macular Degeneration (wAMD)	Pre-clinical

Leadership Team at Drive Therapeutics

Co-Founder & CSO

Co-Founder & COO

View full Drive Therapeutics profile